Long-term follow-up of two chemotherapy protocols in Hodgkin's disease. 1981

S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio

UI MeSH Term Description Entries
D008130 Lomustine An alkylating agent of value against both hematologic malignancies and solid tumors. CCNU,Belustine,Cecenu,CeeNU,NSC-79037,NSC 79037,NSC79037
D008297 Male Males
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
December 1982, British medical journal (Clinical research ed.),
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
May 2002, The New England journal of medicine,
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
July 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
August 1988, American journal of clinical oncology,
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
October 1981, The American journal of medicine,
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
December 2005, International journal of radiation oncology, biology, physics,
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
January 1988, Folia haematologica (Leipzig, Germany : 1928),
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
September 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
February 1991, Australian and New Zealand journal of medicine,
S Pavlovsky, and M Morgenfeld, and N Somoza, and J Magnasco, and F Sackmann Muriel, and F Cavagnaro, and A Suárez, and C A Barros, and J Saslavsky, and G Garay, and M Palau, and S C Besuschio
February 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!